Vasoactive Amines and Inotropic Agents

  • Keith P. Lewis
  • R. Mauricio Gonzalez
  • Konstantin Balonov


One of the central goals of the clinician caring for critically ill patients is to maintain hemodynamic stability. This requires knowledge of the anatomy and physiology of the autonomic nervous system, the cardiovascular system, and their interaction. This chapter reviews the autonomic innervation of the heart and peripheral circulation and the cardiovascular effects of the vasoactive amines and various inotropes.


Renal Blood Flow Systemic Vascular Resistance Pulmonary Capillary Wedge Pressure Coronary Blood Flow Parasympathetic Nervous System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Lawson NW, Meyer DJ. Autonomic nervous system: physiology and pharmacology. In: Barash PG, Cullen BF, Stoelting RK, editors. Clinical anesthesia. Philadelphia: Lippincot-Raven; 1997. p. 243–309.Google Scholar
  2. 2.
    Rozec B, Gauthier C. beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther. 2006;111:652–673.PubMedCrossRefGoogle Scholar
  3. 3.
    Strosberg AD. Association of beta-3-adrenoceptor polymorphism with obesity and diabetes: current status. Trends Pharmacol Sci. 1997;18:449–455.PubMedGoogle Scholar
  4. 4.
    Shihara N, Yasuda K, Moritani T, et al. The association between Trp64Arg polymorphism of the beta 3-adrenergic receptor and autonomic nervous system activity. J Clin Endocrinol Metab. 1999;84:1623–1627.PubMedCrossRefGoogle Scholar
  5. 5.
    Oliver G, Schäfer EA. The physiological effects of extracts of the suprarenal capsules. J Physiol. 1895;18:230–276.PubMedGoogle Scholar
  6. 6.
    Hoffman BB, Lefkowitz RJ. Cathecolamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman GA, editors. Goodman & Gilman’s: The pharmacological basis of therapeutics. New York: McGraw-Hill; 1996. p. 199–248.Google Scholar
  7. 7.
    Stoelting RK, Hiller SC. Pharmacology and physiology in anesthetic practice. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 292–310.Google Scholar
  8. 8.
    DiSesa VJ. The rational selection of inotropic drugs in cardiac surgery. J Card Surg. 1987;2:385–406.PubMedCrossRefGoogle Scholar
  9. 9.
    Struthers AD, Reid JL. The role of adrenal medullary cathecolamines in potassium homeostasis. Clin Sci. 1984;66:377–382.PubMedGoogle Scholar
  10. 10.
    Van Maanen EF, Banning JW, Roebel LE, Morgan JP. Dopamine and norepinephrine increase venous return by stimulating alpha and beta adrenoreceptors in the dog. J Cardiovasc Pharmacol. 1988;11:627–634.PubMedCrossRefGoogle Scholar
  11. 11.
    Beale RJ, Hollenberg SM, Vincent JL, Parrillo JE. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med. 2004;32:S455–S465.PubMedCrossRefGoogle Scholar
  12. 12.
    Di Giantomasso D, Morimatsu H, May CN, Bellomo R. Intrarenal blood flow distribution in hyperdynamic septic shock: effect of norepinephrine. Crit Care Med. 2003;31:2509–2513.PubMedCrossRefGoogle Scholar
  13. 13.
    Martin C, Vivand X, Leone M, et al. Effect of norepinephrine on the outcome of septic shock. Crit Care Med. 2000;28:2758–2765.PubMedCrossRefGoogle Scholar
  14. 14.
    Sumikawa K, Hayashi K, Yamatodani A, Yoshiya I. Contribution of the lungs to the clearance of exogenous dopamine in humans. Anesth Analg. 1991;72:622–626.PubMedCrossRefGoogle Scholar
  15. 15.
    Goldberg LI, Rajfer S. Dopamine receptors: applications in clinical cardiology. Circulation. 1985;72:245–248.PubMedCrossRefGoogle Scholar
  16. 16.
    Baldwin L, Henderson A, Hickman P. Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med. 1994;120:744–747.PubMedCrossRefGoogle Scholar
  17. 17.
    Hilberman M, Maseda J, Stinson E, et al. The diuretic properties of dopamine in patients after open heart operation. Anesthesiology. 1984;61:489–494.PubMedCrossRefGoogle Scholar
  18. 18.
    Goldberg L. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev. 1972;24:1–29.PubMedGoogle Scholar
  19. 19.
    Thompson BT, Cockrill BA. Renal-dose dopamine: a Siren song? Lancet. 1994;334:7–8.CrossRefGoogle Scholar
  20. 20.
    Gelman S. Mushlin PS Catecholamine-induced changes in the splanchic circulation affecting systemic hemodynamics. Anesthesiology. 2004;100:434–439.PubMedCrossRefGoogle Scholar
  21. 21.
    Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med. 1996;24:1580–1590.PubMedCrossRefGoogle Scholar
  22. 22.
    Van den Berghe G, de Zegher F, Wouters P, et al. Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. Clin Endocrinol. 1995;43:457–463.CrossRefGoogle Scholar
  23. 23.
    Devins S, Miller A, Herndon BL, et al. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med. 1992;20:1644–1649.PubMedCrossRefGoogle Scholar
  24. 24.
    DiSesa V, Brown E, Mudge GH, et al. Hemodynamic comparison of dopamine and dobutamine in the postoperative volume-loaded, pressure-loaded, and normal ventricle. J Thorac Cardiovasc Surg. 1982;83:256–263.PubMedGoogle Scholar
  25. 25.
    Butterworth JF, Piccione W, Berrizbeitia LD, et al. Augmentation of venous return by adrenergic agonists during spinal anesthesia. Anesth Analg. 1986;65:612–616.PubMedCrossRefGoogle Scholar
  26. 26.
    Stoelting RK, Hiller SC. Pharmacology and physiology in anesthetic practice. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 317–318.Google Scholar
  27. 27.
    Lewis KP. Early intervention of inotropic support in facilitating weaning from cardiopulmonary bypass: the New England Deaconess Hospital experience. J Cardiothorac Vasc Anesth. 1993;7:40–45.PubMedCrossRefGoogle Scholar
  28. 28.
    Lewis KP. The use of amrinone in noncardiac anesthesia. J Cardiothorac Anesth. 1990;4(5) Suppl 5:34–40.Google Scholar
  29. 29.
    Leier CV. General overview and update of positive inotropic therapy. Am J Med. 1986;81(Suppl 4C):40–45.PubMedCrossRefGoogle Scholar
  30. 30.
    Feneck RO, et al. Intravenous milrinone following cardiac surgery: II. Influence of baseline hemodynamics and patient factors on therapeutic response. J Cardiothorac Vasc Anesth. 1992;6:563–567.PubMedCrossRefGoogle Scholar
  31. 31.
    Treschan TA, Peters J. The vasopressin system: physiology and clinical strategies. Anesthesiology. 2006;105:599–612.PubMedCrossRefGoogle Scholar
  32. 32.
    Laundry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122–1125.CrossRefGoogle Scholar
  33. 33.
    Patel BM, Chittock DR, Russell JA, et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002;96:576–582.PubMedCrossRefGoogle Scholar
  34. 34.
    Sharshar T, Carlier R, Blanchard A, et al. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med. 2002;30:497–500.PubMedCrossRefGoogle Scholar
  35. 35.
    Holmes CL, Granton JT, Landry DW. Science Review: Vasopressin and the cardiovascular system part 2 – clinical physiology. Crit Care. 2004;8:15–23.PubMedCrossRefGoogle Scholar
  36. 36.
    Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999;47:699–703.PubMedCrossRefGoogle Scholar
  37. 37.
    Masutani S, Senzaki H, Ishido H, et al. Vasopressin in the treatment of vasodilatory shock in children. Pediatr Int. 2005;47:132–136.PubMedCrossRefGoogle Scholar
  38. 38.
    Morales DL, Gregg D, Helman DN, et al. Arginin vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg. 2000;69:102–106.PubMedCrossRefGoogle Scholar
  39. 39.
    Chen JM, Cullinane S, Spanier TB, et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation. 1999;100:II244–II246.PubMedGoogle Scholar
  40. 40.
    ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2005;112:IV1–IV203.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Keith P. Lewis
    • 1
  • R. Mauricio Gonzalez
    • 1
  • Konstantin Balonov
    • 1
  1. 1.Department of AnesthesiologyBoston Medical CenterBostonUSA

Personalised recommendations